Buyer's guide · 10 tools
Best AI Radiology Software and Tools in 2026: 10 Radiology AI Platforms Compared
The short answer
There is no single best AI radiology software, because these products solve three different problems. Aidoc and Viz.ai are the reference points for acute triage. Annalise.ai, Qure.ai, Lunit and Gleamer sell finding flags per exam type. Rad AI and PowerScribe One work on the report. Radiological.ai does all three in one assistant on the PACS you already run.
Most "best AI radiology software" lists rank tools that are not competing for the same job. This one groups them by the problem they solve, says who each is genuinely a good fit for, and includes the questions that decide the deal.
Last updated July 2026
Worklist
Structured report
DraftRun the assistant to draft this report for review.
Illustrative sample · not a real patient study, not a diagnosis
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.
Flag · prioritize · draft · you review and sign
Decide the category before you shortlist the vendor. Half of the bad radiology AI purchases are a good tool bought for the wrong minute of the workflow.
How the market splits
Four categories, not one ranking
Radiology AI is sold as one category and bought as four. Knowing which one you need removes most of the shortlist before you take a single demo.
Acute triage
Reorders the worklist so suspected time-critical studies surface first. Value is measured in minutes to treatment. Aidoc and Viz.ai are the reference points here.
Finding flags
Marks regions of interest on the image so a second pair of eyes looks before you sign. Annalise.ai, Qure.ai, Lunit and Gleamer sell this, usually per exam type.
Report drafting
Turns findings into a structured draft and cuts dictation time. Rad AI and PowerScribe One live here. Nothing about the image changes.
Unified assistants
One tool that does all three on the studies you already read. Fewer contracts, one integration, one place to govern. This is where Radiological.ai sits.
Side by side
The 10 AI radiology tools US groups actually shortlist
Described by what each vendor publicly positions itself as doing, and by where it sits in the read. No scores, because a score would just hide the fit question.
| Tool | What it mainly does | Where it sits | Best for |
|---|---|---|---|
| Radiological.ai | Flags suspected findings, prioritizes the worklist and drafts the structured report in one assistant, on X-ray, CT and MRI. | Layers on the PACS you already run, over DICOM. | Groups that want one tool across the whole read instead of three contracts. |
| Aidoc | Acute triage and prioritization across a broad portfolio of clinical modules, mostly on CT. | An enterprise AI platform running alongside PACS, with modules licensed per pathway. | Hospitals and health systems with heavy acute-care CT volume and a budget for a platform. |
| Viz.ai | Care-team triage for time-critical vascular findings, with mobile alerting that reaches the specialist, not only the radiologist. | A coordination layer on top of the acute pathway. | Stroke and cardiovascular service lines where minutes to treatment is the metric. |
| Annalise.ai | Broad finding classifiers on chest X-ray and non-contrast head CT, marketed on the number of findings covered per exam. | Decision support inside the reading workflow. | Departments that want finding breadth on their two highest-volume exam types. |
| Qure.ai | Chest X-ray, head CT and lung nodule pathways, with a large screening and public-health footprint. | Screening and triage ahead of the read. | Screening programs and sites with very high chest volume. |
| Lunit | Detection products for chest X-ray and mammography, plus an oncology biomarker line. | Screening reads, often second-reader style. | Breast and chest screening programs. |
| Gleamer | Per-exam detection products, strongest on trauma and musculoskeletal X-ray. Acquired by RadNet in March 2026 and folded into DeepHealth. | Point tools bought one exam type at a time. | Emergency and orthopedic X-ray volume where fracture support is the priority. |
| Rad AI | Reporting-side AI: impression generation, report drafting and follow-up recommendation tracking. | In the reporting step, after the images are read. | Groups whose bottleneck is dictation time and follow-up leakage, not detection. |
| Nuance PowerScribe One | The radiology reporting and dictation platform of record for much of US radiology, with AI-assisted impressions in the cloud release. | It is the reporting system itself, not a layer on top of one. | Groups already standardized on PowerScribe and planning the 360 to One move. |
| Sirona Medical | A unified radiology operating system that replaces PACS, viewer, worklist and reporter with one product. | It replaces the stack rather than adding to it. | Groups that have already decided to rip and replace the whole imaging stack. |
Reflects general, publicly understood positioning as of July 2026. Capabilities and ownership change, so confirm with each vendor.
Read this before you shortlist
What a comparison table cannot tell you
Three things decide whether radiology AI works in a group, and none of them show up in a feature grid.
The first is case mix. A tool that covers chest X-ray beautifully does very little for a practice reading mostly musculoskeletal MRI. Before you look at vendors, pull your own volume by exam type for the last twelve months and sort it. The top five lines are the only ones that matter. If a shortlisted product does not cover them, the pilot will feel underwhelming no matter how good the technology is.
The second is where the output lands. Results that appear only inside a vendor's own viewer create a second window, and a second window is a tax paid on every study forever. The tools that stick are the ones whose output arrives where the radiologist already is: a flag visible in the study, a worklist that has already been reordered, and a draft sitting in the reporting template. That is the whole argument for radiology PACS integration over DICOM rather than a parallel platform.
The third is vendor stability. This category is consolidating fast. RadNet acquired Gleamer in March 2026 and folded it into DeepHealth. Microsoft owns Nuance, and therefore PowerScribe. Independence at signing is not independence at renewal, and a three-year term signed with a company that gets acquired in year one is a different contract than the one you negotiated. Ask what happens to your pricing and your support tier on a change of control, and get the answer in the agreement.
None of this is a reason to wait. It is a reason to buy for the workflow you have rather than the demo you watched, and to keep the integration surface small enough that swapping a vendor later does not mean rebuilding the reading room.
The six questions
How to evaluate AI radiology software without a bake-off you cannot staff
Six questions that separate a shortlist fast. Ask every vendor the same six and write the answers down, because the differences show up in the answers nobody wants to put in writing.
Does it fit the PACS you already run?
The cheapest integration is the one you do not have to do. Ask whether the tool consumes studies over standard DICOM from your existing archive and returns results your viewer can display, or whether it expects its own worklist and its own viewer.
Breadth versus depth
A point tool that covers one exam type well is easy to justify and easy to outgrow. Four point tools mean four contracts, four integrations, four vendor reviews and four renewal negotiations. Count the true number of tools you would need to cover your case mix.
Where it sits in the read
Triage helps before the study opens. Flags help during. Drafting helps after. Buying two tools that both help before the study opens does not compound. Map each candidate to the minute of the workflow it actually touches.
What happens to the report
Findings that never reach the report are findings the radiologist has to retype. Ask how output lands in your reporting platform, in what format, and whether it arrives as an editable draft in your own template or as a separate PDF nobody opens.
Regulatory posture, stated plainly
Several vendors in this category hold FDA clearances for specific indications, and clearance is per indication rather than for a company. Ask which product, which indication, and which version. Radiological.ai makes no regulatory-status claims on this site and is positioned as decision support for qualified clinicians.
The fully loaded first-year number
List price is the smallest line. Ask for implementation, interface work, template configuration, training hours, per-study or per-module fees, and what the subscription does at renewal in year three. Then compare that total, not the headline.
Money
What AI radiology software actually costs
Any roundup that prints a price for Aidoc or Viz.ai is estimating. Clinical imaging AI is sold through enterprise agreements, and the number depends on modules, study volume, site count and how badly the vendor wants the logo. The honest position is that list pricing is not public, so here is what to ask for instead.
Ask for the fully loaded first-year total: license or subscription, implementation, interface engine work, template configuration, training hours, and any per-study or per-module fee. Then ask what the same total looks like in year three, when the discount that closed the deal has rolled off. Groups that skip the second question are the ones surprised at renewal.
Three pricing models dominate. Per-study fees scale cleanly with volume and are easy to model, but they punish growth. Per-module annual licenses look predictable until you need the fourth module. Per-radiologist subscriptions are the simplest to forecast because headcount changes slowly. Radiological.ai publishes per-radiologist pricing rather than making you sit through a call to find out the range, and the longer breakdown of what drives the number lives in how much radiology AI costs.
One more line that is easy to miss: the time your own people spend. An integration that takes your PACS administrator three weeks is a real cost even though no invoice arrives for it. Ask each vendor how many hours they expect from your team, by role, and compare that alongside the quote.
Where Radiological.ai fits
One assistant across the whole read
We are not the right answer for a health system that needs a specific acute pathway with a named clearance. We are built for the group that wants one tool, one integration and one renewal.
Flags, triage and drafting in one
Suspected findings surface for a second look, the worklist reorders so urgent studies come first, and the structured report drafts into your template. Three problems, one contract, one integration to maintain.
On the PACS you already run
Studies arrive over standard DICOM from the archive you already have. Nothing about the viewer, the archive or the reporting platform has to be replaced for the assistant to be useful on Monday.
Decision support, stated plainly
The assistant flags, prioritizes and drafts. It does not diagnose, and we publish no accuracy figures or regulatory-status claims. The responsible radiologist reviews, edits and signs every study.
Good questions
Best AI radiology software, answered
Keep reading
Go deeper on the shortlist
Radiology AI software
What the assistant does across flagging, worklist order and drafting.
AI triage in radiology
How prioritization changes which study opens next.
Radiology reporting software
Structured reporting and what a draft in your template changes.
AI radiology companies in 2026
How the vendor landscape splits, and how to read it as a buyer.
Vendor evaluation questions
The questions that get honest answers out of a demo.
How to run the trial
Turning a shortlist into a pilot that actually proves something.
See how Radiological.ai reads alongside your group
One assistant that flags suspected findings, prioritizes the worklist, and drafts the structured report on X-ray, CT and MRI. You review and sign every study.
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional medical judgment.